Sign in
Taking people in South KoreaNo phase

Follows adults with tuberculosis to study long-term lung health

Follows adults in treatment for, or treated for, tuberculosis to track lung health.

Key facts

Who runs it
Yonsei University
Where
Seoul, South KoreaSee the site
Trial code
Registry title
LIFE-TB ; Long-Term Impacts on Lung Health and Life After Tuberculosis in Korea
Status
Recruiting
People taking part
360 people, planned
Started
25 Feb 2025
Expected to end
31 Dec 2031
Type of study
Observational
Record updated
27 April 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults who are being treated for lung tuberculosis (TB), or who had treated lung TB in the past. It follows their lung health for five years.

Age
19 years or older
Sex
All sexes can join
Disease stage
Tuberculosis of the lungs, either starting or going through treatment now, or treated in the past
Earlier treatment
People with lung TB can be starting or already on treatment, or have a history of treated lung TB

Main reasons for not taking part

  • Younger than 19 years
  • TB outside the lungs with no lung involvement
  • Refusing to give informed consent

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • Age ≥19 years
  • Diagnosed with pulmonary TB and either initiating or undergoing treatment or history of treated pulmonary TB

Who cannot take part

  • Age <19 years
  • Extrapulmonary TB without lung involvement
  • Refusal to provide informed consent

Where in South Korea

  • Department of Internal Medicine, Yonsei University College of Medicine Division of Pulmonology, Severance Hospital, Yonsei University Health SystemSeoul, South KoreaContact: Young Ae KangTaking people

About the trial

What the trial wants to find out

This is a prospective, multicenter observational cohort study aimed at establishing a nationwide post-TB lung disease registry in Korea. The study will enroll adult participants either undergoing treatment for pulmonary tuberculosis or with a history of treated TB. Over a five-year follow-up period, the study will assess the long-term health consequences of TB, focusing on respiratory symptoms, radiological changes, pulmonary function, and quality of life.

The group in the trial

  • Active TB patients initiating or undergoing treatment or Post-treatment TB survivors

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
LIFE-TB ; Long-Term Impacts on Lung Health and Life After Tuberculosis in Korea
Plain-language title
Follows adults with tuberculosis to study long-term lung healthGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Publications
Record updated
27 April 2025